Browsing: Medicare Reimbursement

The Health Tech Investment Act aims to modernize Medicare’s reimbursement structure for AI-enabled medical devices and algorithm-based healthcare services.

New bill aims to create stable payment pathway for AI healthcare services under Medicare

Nexalin Technology, Inc. announces its support for the Health Tech Investment Act (S. 1399), bipartisan legislation that would expand Medicare reimbursement opportunities for FDA-cleared medical devices incorporating AI or machine learning.

NXL backs bipartisan legislation to expand Medicare reimbursement for AI-enabled medical devices

Nexalin Technology, Inc. announces its support for the Health Tech Investment Act (S. 1399), bipartisan legislation introduced in the United States Senate that would expand Medicare reimbursement opportunities for FDA-cleared or approved medical devices incorporating artificial intelligence (AI) or machine learning.

Nexalin Technology expresses strong support for the Health Tech Investment Act, a bipartisan legislation aimed at expanding Medicare reimbursement for AI-enabled medical devices